0.707
price down icon5.73%   -0.043
after-market 시간 외 거래: .71 0.003 +0.42%
loading

Renovaro Inc 주식(RENB)의 최신 뉴스

pulisher
Jan 19, 2025

Short Interest in Renovaro Inc. (NASDAQ:RENB) Rises By 30.7% - MarketBeat

Jan 19, 2025
pulisher
Jan 13, 2025

Renovaro Inc. appoints new CFO Nathen Fuentes By Investing.com - Investing.com South Africa

Jan 13, 2025
pulisher
Jan 13, 2025

Renovaro Inc. appoints new CFO Nathen Fuentes - Investing.com

Jan 13, 2025
pulisher
Jan 11, 2025

Geode Capital Management LLC Decreases Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World

Jan 11, 2025
pulisher
Jan 11, 2025

Barclays PLC Has $34,000 Stock Position in Renovaro Inc. (NASDAQ:RENB) - Defense World

Jan 11, 2025
pulisher
Jan 09, 2025

Renovaro To Buy Predictive Oncology in All-Stock Deal - Pulse 2.0

Jan 09, 2025
pulisher
Jan 09, 2025

Renovaro Biosciences Subsidiary Appoints New CEO - MSN

Jan 09, 2025
pulisher
Jan 08, 2025

Renovaro appoints Nathen Fuentes as finance chief - MSN

Jan 08, 2025
pulisher
Jan 08, 2025

Renovaro Biosciences Merges with Predictive Oncology - MSN

Jan 08, 2025
pulisher
Jan 08, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Predictive Oncology Inc.POAI - The Malaysian Reserve

Jan 08, 2025
pulisher
Jan 07, 2025

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc.POAI - Marketscreener.com

Jan 07, 2025
pulisher
Jan 07, 2025

Renovaro Inc. appoints new CEO for subsidiary By Investing.com - Investing.com Australia

Jan 07, 2025
pulisher
Jan 07, 2025

Nathen Fuentes Joins Renovaro as Chief Financial Officer - citybiz

Jan 07, 2025
pulisher
Jan 07, 2025

Renovaro BioSciences issues shareholder letter, provides corporate update - TipRanks

Jan 07, 2025
pulisher
Jan 07, 2025

Renovaro Taps Nathen Fuentes as Finance Chief - MarketWatch

Jan 07, 2025
pulisher
Jan 07, 2025

Renovaro Issues Shareholder Letter and Provides Corporate Update - The Manila Times

Jan 07, 2025
pulisher
Jan 07, 2025

Renovaro Inc. appoints new CEO for subsidiary - Investing.com

Jan 07, 2025
pulisher
Jan 06, 2025

Renovaro To Buy Predictive Oncology In All-Stock Deal - Pulse 2.0

Jan 06, 2025
pulisher
Jan 06, 2025

Predictive Oncology shares rise 71% as takeover by Renovaro is announced - Mugglehead

Jan 06, 2025
pulisher
Jan 06, 2025

Renovaro to Acquire Predictive Oncology - citybiz

Jan 06, 2025
pulisher
Jan 06, 2025

M&A: Predictive Oncology to be Acquired by Renovaro - HIT Consultant

Jan 06, 2025
pulisher
Jan 06, 2025

POAI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Predictive Oncology Inc. Is Fair to Shareholders - Business Wire

Jan 06, 2025
pulisher
Jan 06, 2025

Renovaro to acquire Predictive Oncology in all-stock transaction - TipRanks

Jan 06, 2025
pulisher
Jan 06, 2025

Renovaro to Acquire Predictive Oncology in All-Stock Transaction - The Manila Times

Jan 06, 2025
pulisher
Jan 06, 2025

Predictive Oncology in Deal to Be Sold to Renovaro - MarketWatch

Jan 06, 2025
pulisher
Jan 06, 2025

Renovaro to Acquire Predictive Oncology in All-Stock Transaction - Benzinga

Jan 06, 2025
pulisher
Jan 06, 2025

Predictive Oncology Announces Agreement to be Acquired by Renovaro - GlobeNewswire

Jan 06, 2025
pulisher
Jan 06, 2025

Predictive Oncology to Be Acquired by Renovaro in AI-Driven Cancer Research Merger - StockTitan

Jan 06, 2025
pulisher
Jan 05, 2025

Renovaro Inc. entered into a binding letter of intent to acquire Predictive Oncology Inc. for for $6.2 million. - Marketscreener.com

Jan 05, 2025
pulisher
Jan 04, 2025

State Street Corp Acquires 48,114 Shares of Renovaro Inc. (NASDAQ:RENB) - Defense World

Jan 04, 2025
pulisher
Dec 31, 2024

Short Interest in Renovaro Inc. (NASDAQ:RENB) Expands By 27.7% - MarketBeat

Dec 31, 2024
pulisher
Dec 30, 2024

Renovaro appoints new CEO for AI-driven diagnostics arm By Investing.com - Investing.com South Africa

Dec 30, 2024
pulisher
Dec 30, 2024

Renovaro Inc. Appoints Maurice van Tilburg as CEO of RenovaroCube Amid Strategic Growth in AI-Powered Cancer Diagnostics - Tandav Media

Dec 30, 2024
pulisher
Dec 30, 2024

Renovaro appoints new CEO for AI-driven diagnostics arm - Investing.com India

Dec 30, 2024
pulisher
Dec 30, 2024

Renovaro Inc. Appoints Maurice van Tilburg as CEO of RenovaroCube to Advance AI-Powered Cancer Diagnostics - Tandav Media

Dec 30, 2024
pulisher
Dec 30, 2024

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV - The Manila Times

Dec 30, 2024
pulisher
Dec 24, 2024

RENB Stock Price and Chart — NASDAQ:RENB - TradingView

Dec 24, 2024
pulisher
Dec 23, 2024

Renovaro Inc. Receives Grant Approval for LUMINA Project, an AI-Powered Minimal Residual Disease Detection Platform for Lung Cancer - Nasdaq

Dec 23, 2024
pulisher
Dec 23, 2024

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program - GlobeNewswire

Dec 23, 2024
pulisher
Dec 20, 2024

Renovaro regains Nasdaq compliance with bid price rule - Investing.com India

Dec 20, 2024
pulisher
Dec 20, 2024

Renovaro Regains Compliance with NASDAQ Listing Requirement - The Manila Times

Dec 20, 2024
pulisher
Dec 20, 2024

Strategic Collaboration with Nebul to Employ NVIDIA Cutting - openPR

Dec 20, 2024
pulisher
Dec 20, 2024

Renovaro teams up with Nebul for AI-driven cancer detection - Investing.com

Dec 20, 2024
pulisher
Dec 20, 2024

Renovaro Inc. Partners with Nebul to Launch GEDi CUBE Next Generation AI Healthcare Cloud Solutions - Nasdaq

Dec 20, 2024
pulisher
Dec 20, 2024

Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection - GlobeNewswire

Dec 20, 2024
pulisher
Dec 14, 2024

Renovaro (NASDAQ:RENB) Stock Price Up 2.3%Here's What Happened - MarketBeat

Dec 14, 2024
pulisher
Nov 21, 2024

Renovaro (NASDAQ:RENB) Trading Up 6.5%What's Next? - MarketBeat

Nov 21, 2024
pulisher
Nov 16, 2024

Renovaro: Fiscal Q1 Earnings Snapshot - New Haven Register

Nov 16, 2024
$30.75
price down icon 0.65%
$71.93
price down icon 0.75%
$19.03
price up icon 4.62%
$358.93
price down icon 2.04%
biotechnology ONC
$210.08
price up icon 2.31%
$111.93
price down icon 0.74%
자본화:     |  볼륨(24시간):